BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27001456)

  • 1. Altered expression of ATP-sensitive K(+) channels in Hirschsprung's disease.
    Tomuschat C; O'Donnell AM; Coyle D; Dreher N; Kelly D; Puri P
    J Pediatr Surg; 2016 Jun; 51(6):948-52. PubMed ID: 27001456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of IL36γ and IL36 receptor (IL1RL2) in the colon of patients with Hirschsprung's disease.
    Tomuschat C; O'Donnell AM; Coyle D; Puri P
    Pediatr Surg Int; 2017 Feb; 33(2):181-186. PubMed ID: 27853811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered goblet cell function in Hirschsprung's disease.
    Nakamura H; Tomuschat C; Coyle D; O'Donnel AM; Lim T; Puri P
    Pediatr Surg Int; 2018 Feb; 34(2):121-128. PubMed ID: 29383490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Act1/IL-17R expression in Hirschsprung's disease.
    Tomuschat C; O'Donnell AM; Coyle D; Puri P
    Pediatr Surg Int; 2016 Dec; 32(12):1201-1207. PubMed ID: 27660002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of the NLRP6 inflammasome in the colon of patients with Hirschsprung's disease.
    Tomuschat C; Virbel CR; O'Donnell AM; Puri P
    J Pediatr Surg; 2019 Aug; 54(8):1573-1577. PubMed ID: 30262203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOS-interacting protein (NOSIP) is increased in the colon of patients with Hirschsprungs's disease.
    Tomuschat C; O'Donnell AM; Coyle D; Dreher N; Kelly D; Puri P
    J Pediatr Surg; 2017 May; 52(5):772-777. PubMed ID: 28196663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered tryptophan hydroxylase 2 expression in enteric serotonergic nerves in Hirschsprung's-associated enterocolitis.
    Coyle D; Murphy JM; Doyle B; O'Donnell AM; Gillick J; Puri P
    World J Gastroenterol; 2016 May; 22(19):4662-72. PubMed ID: 27217698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of voltage-gated Kv11.1 (hERG) K(+) channels in aganglionic colon in Hirschsprung's disease.
    Tomuschat C; O'Donnell AM; Coyle D; Puri P
    Pediatr Surg Int; 2016 Jan; 32(1):9-16. PubMed ID: 26519040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of a two-pore domain (K2P) mechano-gated potassium channel TREK-1 in Hirschsprung's disease.
    Tomuschat C; O'Donnell AM; Coyle D; Dreher N; Kelly D; Puri P
    Pediatr Res; 2016 Nov; 80(5):729-733. PubMed ID: 27384506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of hyperpolarisation-activated cyclic nucleotide-gated channel 3 in Hirschsprung's disease.
    O'Donnell AM; Coyle D; Puri P
    World J Gastroenterol; 2015 May; 21(18):5635-40. PubMed ID: 25987789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of caveolin-1 in the colon of patients with Hirschsprung's disease.
    Nakamura H; O'Donnell AM; Tomuschat C; Coyle D; Puri P
    Pediatr Surg Int; 2019 Sep; 35(9):929-934. PubMed ID: 31256294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered distribution of small-conductance calcium-activated potassium channel SK3 in Hirschsprung's disease.
    Coyle D; O'Donnell AM; Puri P
    J Pediatr Surg; 2015 Oct; 50(10):1659-64. PubMed ID: 25783396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased protease activated receptors in the colon of patients with Hirschsprung's disease.
    Tomuschat C; O'Donnell AM; Coyle D; Puri P
    J Pediatr Surg; 2020 Aug; 55(8):1488-1494. PubMed ID: 31859043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of inflammasomes in Hirschsprung's disease.
    Nakamura H; O'Donnell AM; Marayati NF; Tomuschat C; Coyle D; Puri P
    Pediatr Surg Int; 2019 Jan; 35(1):15-20. PubMed ID: 30386901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered neurotransmitter expression profile in the ganglionic bowel in Hirschsprung's disease.
    Coyle D; O'Donnell AM; Gillick J; Puri P
    J Pediatr Surg; 2016 May; 51(5):762-9. PubMed ID: 26951962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of hydrogen sulfide synthesis enzymes cystathionine-β-synthase and cystathionine-γ-lyase in the colon of patients with Hirschsprungs disease.
    Tomuschat C; O'Donnell AM; Coyle D; Puri P
    J Pediatr Surg; 2018 Mar; 53(3):525-530. PubMed ID: 28689885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of anoctamin 1 (ANO1) to evaluate interstitial cells of Cajal in Hirschsprung's disease.
    Coyle D; Kelly DA; O'Donnell AM; Gillick J; Puri P
    Pediatr Surg Int; 2016 Feb; 32(2):125-33. PubMed ID: 26510736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of Kv7 channels in Hirchsprung's disease.
    O'Donnell AM; Coyle D; Puri P
    J Pediatr Surg; 2017 Jul; 52(7):1177-1181. PubMed ID: 28087137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease in patients with Hirschsprung's disease: a systematic review and meta-analysis.
    Nakamura H; Lim T; Puri P
    Pediatr Surg Int; 2018 Feb; 34(2):149-154. PubMed ID: 28983688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal Scn1b and Fxyd1 gene expression in the pulled-through ganglionic colon may influence functional outcome in patients with Hirschsprung's disease.
    O'Donnell AM; Nakamura H; Tomuschat C; Marayati NF; Puri P
    Pediatr Surg Int; 2019 Jan; 35(1):9-14. PubMed ID: 30386899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.